Charles River Laboratories International Inc (CRL)

Add to Watchlists
Create an Alert
127.99 -0.67  -0.52% NYSE Oct 22, 12:31 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/07/2019 08:30 EST Misc Charles River Laboratories International Inc Third Quarter Earnings Conference Call in 2019
11/07/2019 Earnings Charles River Laboratories International Inc Third Quarter Earnings in 2019 Release
07/31/2019 08:30 EDT Misc Charles River Laboratories International Inc Second Quarter Earnings Conference Call in 2019
07/31/2019 Earnings Charles River Laboratories International Inc Second Quarter Earnings in 2019 Release
05/21/2019 08:00 EDT Misc Charles River Laboratories International Inc Annual General Meeting in 2018
05/07/2019 08:30 EDT Misc Charles River Laboratories International Inc First Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Charles River Laboratories International Inc First Quarter Earnings in 2019 Release
02/13/2019 08:30 EST Misc Charles River Laboratories International Inc Fourth Quarter Earnings Conference Call in 2018
02/13/2019 Earnings Charles River Laboratories International Inc Fourth Quarter Earnings in 2018 Release
02/13/2019 Misc Charles River Laboratories International Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.criver.com
  • Investor Relations URL: http://ir.criver.com/phoenix.zhtml?c=121668&p=irol-presentations
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 07, 2019
  • Last Earnings Release: Jul. 31, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.

Top Fund Holders

Symbol Name Weighting
FBT First Trust NYSE Arca Biotech ETF 3.32%
BBH VanEck Vectors Biotech ETF 3.09%
BASAX Brown Advisory Small-Cap Growth Adv 2.80%
FID5171 Fidelity Small Cap America Series E2T5 2.69%
FID5685 Fidelity Small Cap America Cl P4T5 2.69%
FSCRX Fidelity® Small Cap Discovery 2.32%
JSMD Janus Henderson Small/Md Cp Gr Alpha ETF 2.08%
FAGKX Fidelity® Growth Strategies K 1.51%
HTEC Robo Global® Hlthcare Tech & Innovt ETF 1.47%
VSEQX Vanguard Strategic Equity Inv 0.73%
SCHA Schwab US Small-Cap ETF™ 0.25%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.